UK Renal Registry 9 th Annual Report 2006 Fig 14.1 Height Z scores for ERF patients aged 2 to 16 years in 2005.

Slides:



Advertisements
Similar presentations
UK Renal Registry 13th Annual Report Figure 12.1: Median height z-scores for transplant patients in 2009.
Advertisements

UK Renal Registry 15th Annual Report Figure One year death rate per 1,000 patient years by UK country and age group for prevalent dialysis.
UK Renal Registry 16th Annual Report Figure 5.1. Flow chart showing number of patients included in the various analyses.
UK Renal Registry 16th Annual Report Figure 8.1. Trend in 1 year after 90 day incident patient survival by first modality, 2005–2011 cohort (adjusted to.
UK Renal Registry 17th Annual Report Figure 9.1. Median height z-scores for transplant patients
UK Renal Registry 16th Annual Report Figure Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2012.
UK Renal Registry 14th Annual Report Figure 8.1. Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2010.
UK Renal Registry 17th Annual Report Figure 3.1. Transplant prevalence rate per million population by age and gender on 31/12/2013.
UK Renal Registry 14th Annual Report Figure 3.1. Transplant prevalence rate per million population by age and gender on 31/12/2010.
UK Renal Registry 9 th Annual Report 2006 Fig 9.1 Percentage of patients with serum phosphate
UK Renal Registry 17th Annual Report Figure Percentage of patients waitlisted for a kidney transplant by renal centre, prior to or within two years.
UK Renal Registry 17th Annual Report Figure 2.1. Prevalence rates per million population by age group and UK country on 31/12/2013.
UK Renal Registry 10th Annual Report 2007 Fig 3.1 Incident rates in the countries of the UK:
© ANZDATA Registry PEADIATRIC CHAPTER CHAPTER 11.
UK Renal Registry 9 th Annual Report 2006 Fig 13.1 ERF patients below 15 years of age, by year of data collection.
ANZDATA Registry Annual Report 2013 Philip Clayton CHAPTER 9 KIDNEY DONATION 2013 Annual Report - 36th Edition PAEDIATRIC CHAPTER 11.
UK Renal Registry 10th Annual Report 2007 Fig 10.1 Summary of BP achievements.
UK Renal Registry 9 th Annual Report 2006 Fig 10.1 Systolic BP mm Hg (pre-HD)
UK Renal Registry 16th Annual Report Figure Summary of BP achievements.
UK Renal Registry 14th Annual Report Figure Summary of BP achievements.
UK Renal Registry 9 th Annual Report 2006 Fig 11.1 UK transplantation prevalence rate per million population by age and gender on 31/12/2005.
UK Renal Registry 17th Annual Report Figure 1.1. RRT incidence rates in the countries of the UK 1990–2013.
UK Renal Registry 10th Annual Report 2007 Fig 8.1 Median haemoglobin for incident dialysis patients at start of dialysis treatment.
UK Renal Registry 15th Annual Report Figure 6.1. Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2011.
UK Renal Registry 15th Annual Report Figure D.1. 95% confidence limits for incidence of 108 pmp for population size 80,000–800,000.
UK Renal Registry 16th Annual Report Figure Median height z-scores for transplant patients
UK Renal Registry 16th Annual Report Figure Box and whisker plot of MRSA rates by renal centre per 100 prevalent dialysis patients per year by reporting.
UK Renal Registry 17th Annual Report Figure 4.1. RRT treatment used by prevalent paediatric patients
UK Renal Registry 10th Annual Report 2007 Fig 9.1 Annual change in percentage of dialysis patients with serum phosphate < 1.8mmol/L and ≥1.1 -≤1.8mmol/L.
UK Renal Registry 15th Annual Report Figure 7.1. Median height z-scores for transplant patients
SPECTRUM OF CHRONIC RENAL FAILURE King Hussein Medical Center Edward Saca MD, MSc.
UK Renal Registry 13th Annual Report
UK Renal Registry 10th Annual Report 2007
ANZDATA Registry 39th Annual Report Chapter 13: End Stage Kidney Disease in Aotearoa/New Zealand Data to 31-Dec-2015.
UK Renal Registry 15th Annual Report
Fig 7.1 Median URR achieved in each renal unit
UK Renal Registry 16th Annual Report
UK Renal Registry 9th Annual Report 2006
UK Renal Registry 10th Annual Report 2007
UK Renal Registry 19th Annual Report
Peer Review Oct 2017 Haemodialysis Graphs.
UK Renal Registry 13th Annual Report
Impact of Cognitive Function Change on Mortality in Renal Transplant and End-Stage Renal Disease Patients Sharma et al. Am J Nephrol 2016;44: (DOI: / )
UK Renal Registry 11th Annual Report
UK Renal Registry 11th Annual Report 2008
UK Renal Registry 13th Annual Report
Fig 6.1 Frequency of ischaemic heart disease in incident patients
UK Renal Registry 13th Annual Report
UK Renal Registry 11th Annual Report
Renal Association UK Renal Registry.
UK Renal Registry 15th Annual Report
UK Renal Registry 16th Annual Report
UK Renal Registry 16th Annual Report
UK Renal Registry 14th Annual Report
UK Cystic Fibrosis Registry Annual Data Report 2017
UK Renal Registry 10th Annual Report 2007
UK Renal Registry 15th Annual Report
UK Renal Registry 14th Annual Report
ANZDATA Registry 41st Annual Report Highlights of End Stage Kidney Disease in Australia and New Zealand Data to 31-Dec-2017.
UK Renal Registry 14th Annual Report
Renal Association UK Renal Registry.
UK Renal Registry 12th Annual Report
Fig 7.1 Median URR achieved in each centre, 2006
UK Renal Registry 10th Annual Report 2007
UK Renal Registry 12th Annual Report
UK Renal Registry 13th Annual Report
Renal Association UK Renal Registry.
UK Renal Registry 11th Annual Report
UK Renal Registry 9th Annual Report 2006
Renal Association UK Renal Registry.
Presentation transcript:

UK Renal Registry 9 th Annual Report 2006 Fig 14.1 Height Z scores for ERF patients aged 2 to 16 years in 2005

UK Renal Registry 9 th Annual Report 2006 Fig 14.2 Height Z scores of dialysis vs transplant patients

UK Renal Registry 9 th Annual Report 2006 Fig 14.3 Height Z scores for patients at presentation and ERF commencement

UK Renal Registry 9 th Annual Report 2006 Fig 14.4 Height Z scores at presentation and ERF commencement

UK Renal Registry 9 th Annual Report 2006 Fig 14.5a Change in height Z score from presentation to ERF commencement in patients with renal dysplasia

UK Renal Registry 9 th Annual Report 2006 Fig 14.5b Distribution of height Z score at presentation and ERF commencement in patients with renal dysplasia

UK Renal Registry 9 th Annual Report 2006 Fig 14.6a Change in height Z score from presentation to ERF commencement in patients with obstructive uropathy

UK Renal Registry 9 th Annual Report 2006 Fig 14.6b Distribution of height Z score at presentation and ERF commencement in patients with obstructive uropathy

UK Renal Registry 9 th Annual Report 2006 Fig 14.7a Change in height Z score from presentation to ERF commencement in patients with reflux nephrology

UK Renal Registry 9 th Annual Report 2006 Fig 14.7b Distribution of height Z score at presentation and ERF commencement in patients with reflux nephrology

UK Renal Registry 9 th Annual Report 2006 Fig 14.8a Change in height Z score from presentation to ERF commencement in patients with tubulo-interstitial disease

UK Renal Registry 9 th Annual Report 2006 Fig 14.8b Distribution of height Z score at presentation and ERF commencement in patients with tubulo-interstitial disease

UK Renal Registry 9 th Annual Report 2006 Fig 14.9a Change in height Z score from presentation to ERF commencement in patients with glomerular disease

UK Renal Registry 9 th Annual Report 2006 Fig 14.9b Distribution of height Z score at presentation and ERF commencement in patients with glomerular disease

UK Renal Registry 9 th Annual Report 2006 Fig 14.10a Change in height Z score from presentation to ERF commencement in patients with cystinosis

UK Renal Registry 9 th Annual Report 2006 Fig 14.10b Distribution of height Z score at presentation and ERF commencement in patients with cystinosis

UK Renal Registry 9 th Annual Report 2006 Fig Height Z score at ERF start and at least one year post transplantation

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.